SEVERE DEPLETION OF CELLULAR THIOLS AND GLUTATHIONE-RELATED ENZYMES OF A CARMUSTINE-RESISTANT L1210 STRAIN ASSOCIATES WITH COLLATERAL SENSITIVITY TO CYCLOPHOSPHAMIDE

被引:4
作者
INSTITORIS, E [1 ]
TRETTER, L [1 ]
GAAL, D [1 ]
机构
[1] SEMMELWEIS UNIV MED,SCH MED,INST BIOCHEM 2,H-1085 BUDAPEST 8,HUNGARY
关键词
GLUTATHIONE; L1210; BCNU; COLLATERAL SENSITIVITY; RESISTANCE;
D O I
10.1007/BF00686029
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cyclophosphamide (CPA) increased the life span of both carmustine (BCNU)-resistant (L1210/BCNU) and BCNU-sensitive L1210 (L1210/0) leukaemic mice; their sensitivity to CPA, however, was extremely different. The BCNU-resistant strain was much more sensitive (collaterally) to CPA than was its sensitive counterpart. The collateral sensitivity was accompanied by a severe reduction in the activity of glutathione-related enzymes and in protein thiol (SH) and non-protein SH levels in BCNU-resistant cells. The activity of glutathione reductase (GSSG-R) was 2 times higher in the L1210/0 cells than in the L1210/BCNU cells. Glutathione-S-transferase (GST) was also almost 2 times more active in the sensitive cells than in the resistant strain. To develop resistance against CPA with a single treatment (60 mg/kg) per passage, the L1210/BCNU strain needed 26 passages, whereas the L1210/0 strain required significantly fewer. The resistance developed against CPA was associated with a moderate elevation of thiols in the L1210/CPA cells, whereas this elevation was approximately 3 times more pronounced in the L1210/BCNU/CPA cells. The severely reduced activity of GST in the L1210/BCNU strain was markedly increased when these cells were made resistant to CPA; the GSSG-R activity, however, remained low, suggesting an irreversible injury of this enzyme by BCNU.
引用
收藏
页码:85 / 88
页数:4
相关论文
共 24 条
[1]   INACTIVATION OF GLUTATHIONE REDUCTASE BY 2-CHLOROETHYL NITROSOUREA-DERIVED ISOCYANATES [J].
BABSON, JR ;
REED, DJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1978, 83 (02) :754-762
[2]  
BOYLAND E, 1969, ADV ENZYMOL RAMB, V32, P173
[3]  
BULLER AL, 1987, MOL PHARMACOL, V31, P575
[4]  
CHRESTA CM, 1990, CANCER RES, V50, P4067
[5]   CHARACTERIZATION OF THE INHIBITION OF GLUTATHIONE-REDUCTASE AND THE RECOVERY OF ENZYME-ACTIVITY IN EXPONENTIALLY GROWING MURINE LEUKEMIA (L1210) CELLS TREATED WITH 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA [J].
COHEN, MB ;
DUVEL, DL .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (17) :3317-3320
[6]  
CROOK TR, 1986, CANCER RES, V46, P5035
[7]   DNA CROSS-LINKING AND MONOADDUCT REPAIR IN NITROSOUREA-TREATED HUMAN-TUMOR CELLS [J].
ERICKSON, LC ;
LAURENT, G ;
SHARKEY, NA ;
KOHN, KW .
NATURE, 1980, 288 (5792) :727-729
[8]  
EVANS CG, 1987, CANCER RES, V47, P2525
[9]  
FRISCHER H, 1977, J LAB CLIN MED, V89, P1080
[10]   GLUTATHIONE AND GLUTATHIONE S-TRANSFERASES IN A HUMAN-PLASMA CELL-LINE RESISTANT TO MELPHALAN [J].
GUPTA, V ;
SINGH, SV ;
AHMAD, H ;
MEDH, RD ;
AWASTHI, YC .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (12) :1993-2000